BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

«Hallucinogens Drug Abuse

Below is an extended Hallucinogens Drug Abuse research listing. Click here to return to the Hallucinogens Drug Abuse main in depth entry.

Recent Publications on Hallucinogens Drug Abuse:

Multivariate modeling of club drug use initiation among gay and bisexual men.
This paper documents patterns and sequence of initiation of club drug use...
Direct Link
23rd August, 2008
Center for Health, Identity, Behavior & Prevention Studies, Department of
Associations of substance use problems with intimate partner violence for at-risk men in long-term relationships.
Associations of substance use problems in men--defined as a man's meeting...
Direct Link
22nd August, 2008
Oregon Social Learning
Pharmacokinetics of the potent hallucinogen, salvinorin A in primates parallels the rapid onset and short duration of effects in humans.
Salvia divinorum, a mint plant originally used by the Mazatecs of Oaxaca,...
Direct Link
15th August, 2008
Medical Department, Brookhaven National Laboratory, Upton, NY 11973, USA.
[Hallucinogen-induced psychological disorders]
OBJECTIVE: The purpose of this article is to provide an overview of the...
Direct Link
9th August, 2008
Klinik fur Psychiatrie und Psychotherapie Christophsbad, Goppingen.
Current status of cannabis treatment of multiple sclerosis with an illustrative case presentation of a patient with MS, complex vocal tics, paroxysmal dystonia, and marijuana dependence treated with dronabinol. 8th August, 2008
Mental Health Service Line, Department of Veterans Affairs Medical Center,
Plasma pharmacokinetics of 3,4-methylenedioxymethamphetamine after controlled oral administration to young adults.
This study examines the plasma pharmacokinetics of...
Direct Link
19th July, 2008
Chemistry and Drug Metabolism Section, Intramural Research Program,
In-situ detection of drugs-of-abuse on clothing using confocal Raman microscopy.
This study describes the application of confocal Raman microscopy to the...
Direct Link
11th July, 2008
Raman Spectroscopy Group, University Analytical Centre, Division of
Cannabis and psychiatric disorders: it is not only addiction.
Since the discovery of the endocannabinoid system, a growing body of...
Direct Link
9th July, 2008
Department of Psychiatry and Psychotherapy, University of Cologne,
Puberty as a highly vulnerable developmental period for the consequences of cannabis exposure.
During puberty, neuronal maturation of the brain, which began during...
Direct Link
9th July, 2008
Central Institute of Mental Health (ZI), Department of Psychopharmacology,
Ligands that target cannabinoid receptors in the brain: from THC to anandamide and beyond.
A major finding--that (-)-trans-Delta(9)-tetrahydrocannabinol...
Direct Link
9th July, 2008
School of Medical Sciences, Institute of Medical Sciences, University of
The endocannabinoid system: emotion, learning and addiction.
The identification of the cannabinoid receptor type 1 (CB1 receptor) was...
Direct Link
9th July, 2008
Department of Physiological Chemistry, Johannes Gutenberg University
DMT at fifty. 27th June, 2008
From ultrasocial to antisocial: a role for oxytocin in the acute reinforcing effects and long-term adverse consequences of drug use?
Addictive drugs can profoundly affect social behaviour both acutely and in...
Direct Link
20th June, 2008
School of Psychology, University of Sydney, Sydney, Australia.
Trends in population drug use in New Zealand: findings from national household surveying of drug use in 1998, 2001, 2003, and 2006. 18th June, 2008
Centre for Social and Health Outcomes Research and Evaluation, Massey
[Bromo-dragon fly--life-threatening drug. Can cause tissue necrosis as demonstrated by the first described case] 6th June, 2008
Anestesi- och intensivvardskliniken, Universitetssjukhuset i Lund.
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional